Effect of hyperlipidemic diets, proinflammatory agents and plasma expanders on leukocyte adhesion to the endothelium of aorta and carotid artery of rats.
A comparative study of leukocyte adhesion to the endothelium of the thoracic aorta and left carotid artery in rats has been performed after administration of two hyperlipidemic diets for 15 days, proinflammatory agents (thrombin, lipopolysaccharide and zymosan activated serum) and plasma expanders [dextran, polyvinylpyrrolidone (PVP), rat albumin and several bovine albumins from different sources]. Leukocytes adhered to the endothelium were demonstrated in surface preparations by esterase activity. Activation of circulating leukocytes was measured by nitroblue tetrazolium reduction and luminol enhanced chemiluminescence. Both hyperlipidemic diets produced, in all rats, more leukocyte adhesion in the aorta than in the carotid artery. All proinflammatory agents produced at 1 h, increases in leukocyte adhesion--which in all rats were greater in the carotid artery than in the aorta--and leukocyte activation, which was higher at 3 h than at 1 h. Dextran, PVP, bovine albumins 103700 and A-4503 at 18 h produced slight increases in leukocyte adhesion in the aorta but not in the carotid artery. Rat albumin and bovine albumin A-7906 determined an intense leukocyte adhesion at 18 h which was not preferential to either vessel. Adhesion produced by A-7906 was maximal at 12 h and partially inhibited by dexamethasone. This last albumin produced leukocyte activation at 3 h and was sequestered 5 min after administration, reaching normal values at 1 h. Albumins 103700 and A-4503 neither activated leukocytes nor were sequestered after administration.
Gabaldón
M
M
Unidad Histoquimia, Hospital La Fe, Valencia, Spain.
Zúñiga
A
A
Capdevila
C
C
Marqués
A
A
D000818:Animals; D001013:Aorta, Thoracic / Q000166:cytology*; D001769:Blood; D043182:Carboxylesterase; D002265:Carboxylic Ester Hydrolases / Q000378:metabolism; D002339:Carotid Arteries / Q000166:cytology*; D002448:Cell Adhesion / Q000187:drug effects; D003911:Dextrans / Q000494:pharmacology; D004041:Dietary Fats / Q000008:administration & dosage*; D004730:Endothelium, Vascular / Q000166:cytology*; D007249:Inflammation / Q000503:physiopathology; D007962:Leukocytes / Q000502:physiology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008163:Luminescent Measurements; D008297:Male; D009580:Nitroblue Tetrazolium; D010952:Plasma Substitutes / Q000494:pharmacology*; D011205:Povidone / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012709:Serum Albumin / Q000494:pharmacology; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology*; D015054:Zymosan / Q000494:pharmacology
D003911:Dextrans; D004041:Dietary Fats; D008070:Lipopolysaccharides; D010952:Plasma Substitutes; D012709:Serum Albumin; D012710:Serum Albumin, Bovine; D009580:Nitroblue Tetrazolium; D015054:Zymosan; D002265:Carboxylic Ester Hydrolases; D043182:Carboxylesterase; D013917:Thrombin; D011205:Povidone